期刊
JOURNAL OF NEURO-OPHTHALMOLOGY
卷 29, 期 1, 页码 43-49出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WNO.0b013e318199becf
关键词
-
资金
- Research to Prevent Blindness
- National Eye Institute Core [1 P30 EY12576-04]
Autoimmune-related retinopathy and optic neuropathy (ARRON) syndrome is characterized by visual loss and often the presence of antibodies against retinal or optic nerve antigens in the absence of cancer. Limited success has been reported in treatment of ARRON syndrome with medications that suppress the immune system. In many patients, current strategies are insufficient to control the disease. A 47-year-old woman with progressive visual and hearing loss attributed to ARRON syndrome that was resistant to conventional therapies underwent autologous hematopoietic stem cell transplantation (HSCT). Clinical manifestations appeared to stabilize. This report suggests that autologous HSCT may have a therapeutic role in ARRON syndrome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据